ENZON PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Enzon Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 2, 2024 was 74.2M shares, unchanged year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 74.2M 0 0% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 74.2M 0 0% Apr 18, 2024 10-K/A 2024-04-26
Q3 2023 74.2M 0 0% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 74.2M 0 0% Jul 27, 2023 10-Q 2023-08-07
Q1 2023 74.2M 0 0% Apr 28, 2023 10-Q 2023-05-05
Q4 2022 74.2M 0 0% Feb 10, 2023 10-K 2023-02-16
Q3 2022 74.2M 0 0% Nov 4, 2022 10-Q 2022-11-09
Q2 2022 74.2M 0 0% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 74.2M 0 0% Apr 15, 2022 10-Q 2022-04-26
Q4 2021 74.2M 0 0% Feb 11, 2022 10-K 2022-02-25
Q3 2021 74.2M 0 0% Oct 29, 2021 10-Q 2021-11-05
Q2 2021 74.2M +30M +67.9% Jul 31, 2021 10-Q 2021-08-05
Q1 2021 74.2M +30M +67.9% Apr 23, 2021 10-Q 2021-05-04
Q4 2020 74.2M +30M +67.9% Feb 12, 2021 10-K 2021-02-23
Q3 2020 74.2M +30M +67.9% Oct 30, 2020 10-Q 2020-11-09
Q2 2020 44.2M 0 0% Jul 17, 2020 10-Q 2020-07-29
Q1 2020 44.2M 0 0% Apr 24, 2020 10-Q 2020-04-30
Q4 2019 44.2M 0 0% Feb 7, 2020 10-K 2020-02-19
Q3 2019 44.2M 0 0% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 44.2M 0 0% Aug 2, 2019 10-Q 2019-08-07
Q1 2019 44.2M 0 0% May 3, 2019 10-Q 2019-05-08
Q4 2018 44.2M Feb 8, 2019 10-K 2019-02-21
Q3 2018 44.2M 0 0% Nov 2, 2018 10-Q 2018-11-07
Q2 2018 44.2M 0 0% Aug 3, 2018 10-Q 2018-08-10
Q1 2018 44.2M 0 0% Mar 2, 2018 10-K 2018-03-21
Q3 2017 44.2M 0 0% Oct 31, 2017 10-Q 2017-11-09
Q2 2017 44.2M +348K +0.79% Aug 4, 2017 10-Q 2017-08-10
Q1 2017 44.2M 0 0% Mar 22, 2017 10-K 2017-03-24
Q3 2016 44.2M +32.2K +0.07% Oct 31, 2016 10-Q 2016-11-10
Q2 2016 43.9M -316K -0.72% Aug 1, 2016 10-Q 2016-08-10
Q1 2016 44.2M +32.2K +0.07% Mar 11, 2016 10-K 2016-03-21
Q3 2015 44.2M +40.1K +0.09% Oct 30, 2015 10-Q 2015-11-06
Q2 2015 44.2M +57K +0.13% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 44.2M +88.9K +0.2% May 6, 2015 10-Q 2015-05-13
Q3 2014 44.1M +74K +0.17% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 44.1M +215K +0.49% Aug 1, 2014 10-Q 2014-08-08
Q1 2014 44.1M +400K +0.92% Mar 6, 2014 10-K 2014-03-14
Q3 2013 44.1M -349K -0.79% Nov 1, 2013 10-Q 2013-11-12
Q2 2013 43.9M -2.93M -6.26% Aug 1, 2013 10-Q 2013-08-06
Q1 2013 43.7M -4.61M -9.55% Mar 12, 2013 10-K 2013-03-18
Q3 2012 44.4M -3.87M -8.02% Oct 24, 2012 10-Q 2012-11-09
Q2 2012 46.8M -1.85M -3.79% Jul 31, 2012 10-Q/A 2012-08-21
Q1 2012 48.3M Apr 25, 2012 10-Q 2012-05-02
Q3 2011 48.3M Oct 31, 2011 10-Q 2011-11-04
Q2 2011 48.7M Aug 1, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.